Anesthetic and Analgesic Drug Products Advisory Committee

Anesthetic and Analgesic Drug Products Advisory Committee,
Committee Meeting on February 9, 2012, from 8:30 a.m. to 4 p.m.

Agenda: The committee will discuss the available efficacy and safety data for supplemental new drug application (sNDA) 22395/S-013, QUTENZA (capsaicin 8%) Patch, by NeurogesX, Inc., for the proposed indication of management of neuropathic pain (nerve pain) related to HIV-associated peripheral neuropathy (nerve pain in the periphery of the body, such as the feet and legs).